EXECUTIVE
SUMMARY
i.
Critical Care Overview
ii.
Vital Signs Patient Monitoring Products Market
iii.
Neurologic Patient Monitoring Products Market
iv. Level of Consciousness Patient
Monitoring Products Market
v.
Hemodynamic Patient Monitoring Products Market
vi.
Methodology
Exhibit ES-1: Europe, Critical
Care Patient Monitoring Products, Combined Market Forecast,
2006-2011
Exhibit ES-2: Europe, Vital Signs
Monitoring Systems, Market Forecast, 2006-2011
Exhibit ES-3: Europe, Neurologic
Monitoring Products, Market Forecast, 2006-2011
Exhibit ES-4: Europe, Level of
Consciousness Monitoring Products, Market Forecast, 2006-2011
Exhibit ES-5: Europe, Hemodynamic
Monitoring Products, Market Forecast, 2006-2011
1.
EUROPEAN HEALTHCARE MARKETS
1.1
The European Union
1.1.1 A Common Currency
1.1.2 Regulatory Policies
1.2 Factors Affecting Healthcare Delivery
in the European Union
1.2.1 Aging Population
1.2.2 Healthcare Spending
1.2.3 Hospital Group Purchasing Organizations
1.2.4 Reimbursement
1.2.5 Community-Based Healthcare
1.3
Selected European National Healthcare Profiles
1.3.1 France
1.3.1.1 Healthcare Organization and Reform
1.3.1.2 Hospital Services
1.3.1.3 Medical Device Reimbursement
1.3.2 Germany
1.3.2.1 Healthcare Organization and Reform
1.3.2.2 Hospital Services
1.3.2.3 Medical Device Reimbursement
1.3.3
Italy
1.3.3.1 Healthcare Organization and Reform
1.3.3.2 Hospital Services
1.3.3.3 Medical Device Reimbursement
1.3.4
Spain
1.3.4.1 Healthcare Organization and Reform
1.3.4.2 Hospital Services
1.3.4.3 Medical Device Reimbursement
1.3.5
United Kingdom
1.3.5.1 Healthcare Organization and Reform
1.3.5.2 Hospital Services
1.3.5.3 Medical Device Reimbursement
Exhibit 1-1: European Union,
Medical Devices Risk Classification System
Exhibit 1-2: 2007, Europe, Population
Statistics, Selected Countries
Exhibit 1-3: France, Selected
National Healthcare Statistics
Exhibit 1-4: Germany, Selected
National Healthcare Statistics
Exhibit 1-5: Italy, Selected
National Healthcare Statistics
Exhibit 1-6: Spain, Selected
National Healthcare Statistics
Exhibit 1-7: United Kingdom,
Selected National Healthcare Statistics
2. OVERVIEW OF THE CRITICAL CARE ENVIRONMENT
2.1
Conditions Treated in the Critical Care Unit
2.2
Critical Care Unit Staffing
2.2.1 Intensivists
2.2.2 Nurses and Other Allied Healthcare
Professionals
2.3
Critical Care Units, by Size and Type
2.4 Equipment and Products Used in
the Critical Care Setting
2.4.1 Invasive and Noninvasive Equipment
and Products
2.4.2 Transport Equipment and Products
2.5
Critical Access Hospital Designation
2.6
Issues Affecting Critical Care Delivery
2.6.1 Patient Demographics
2.6.2 Managed Care
2.6.3 Healthcare Personnel Shortages
2.6.4 Trends in Critical Care Product
Purchasing
2.6.5 Device Company Alliances
Exhibit 2-1: 2006, Number of
Anesthetists/Intensivists in Selected European Countries
Exhibit 2-2: Selected Critical
Care Nursing and Allied Healthcare Responsibilities
Exhibit 2-3: 2006, Number of
Emergency Rooms and Beds in Selected European Countries
Exhibit 2-4: 2006, Total Equipped
Positions, by Type of Intensive Care Unit and Facility in Selected
European Countries
Exhibit 2-5: 2006, France, Total
Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-6: 2006, Germany, Total
Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-7: 2006, Italy, Total
Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-8: 2006, Spain, Total
Equipped Positions, by Type of Intensive Care Unit and Facility
Exhibit 2-9: 2006, United Kingdom,
Total Equipped Positions, by Type of Intensive Care Unit and
Facility
3. VITAL SIGNS PATIENT MONITORING
PRODUCTS MARKET
3.1
Information Integration
3.2
Configured Monitoring Systems
3.2.1 Products and Technology
3.2.2 Market Analysis
3.2.3 Competitive Analysis
3.3
Modular Monitoring Systems
3.3.1 Products and Technology
3.3.2 Market Analysis
3.3.3 Competitive Analysis
3.4
Portable Monitoring Systems
3.4.1 Products and Technology
3.4.2 Market Analysis
3.4.3 Competitive Analysis
3.5
Telemetry Monitoring Systems
3.5.1 Products and Technology
3.5.2 Market Analysis
3.5.3 Competitive Analysis
3.6 Vital Signs Monitoring Systems,
Combined Market Analysis
3.6.1 Acquisitions and Mergers
Exhibit 3-1: 2008, Selected Product
Characteristics and Performance Requirements of Configured Vital
Signs Monitoring Systems for Adult Patients
Exhibit 3-2: 2008, Selected Product
Characteristics and Performance Requirements of Configured Vital
Signs Monitoring Systems for Neonatal and Pediatric Patients
Exhibit 3-3: 2008, Selected Configured
Vital Signs Monitoring Systems
Exhibit 3-4: Europe, Configured
Vital Signs Monitoring Systems, Market Forecast, by Country,
2006-2011
Exhibit 3-5: 2007, Europe, Configured
Vital Signs Monitoring Systems Market, Share by Supplier
Exhibit 3-6: Selected Product
Characteristics and Performance Requirements of Modular Vital
Signs Monitoring Systems for Adult Patients
Exhibit 3-7: Selected Product
Characteristics and Performance Requirements of Modular Vital
Signs Monitoring Systems for Neonatal and Pediatric Patients
Exhibit 3-8: 2008, Selected Modular
Vital Signs Monitoring Systems
Exhibit 3-9: Europe, Modular
Vital Signs Monitoring Systems, Market Forecast, by Country,
2006-2011
Exhibit 3-10: 2007, Europe, Modular
Vital Signs Monitoring Systems Market, Share by Supplier
Exhibit 3-11: End-User Needs Supporting
the Emergence of Portable Vital Signs Monitoring Systems
Exhibit 3-12: 2008, Selected Product
Characteristics and Performance Requirements of Portable Vital
Signs Monitoring Systems
Exhibit 3-13: 2008, Selected Portable
Vital Signs Monitoring Systems
Exhibit 3-14: Europe, Portable
Vital Signs Monitoring Systems, Market Forecast, by Country,
2006-2011
Exhibit 3-15: 2007, Europe, Portable
Vital Signs Monitoring Systems Market, Share by Supplier
Exhibit 3-16: 2008, Selected Product
Characteristics and Performance Requirements of Telemetry Vital
Signs Monitoring Systems
Exhibit 3-17: 2008, Selected Telemetry
Vital Signs Monitoring Systems
Exhibit 3-18: Europe, Telemetry
Vital Signs Monitoring Systems, Market Forecast, by Country,
2006-2011
Exhibit 3-19: 2007, Europe, Telemetry
Vital Signs Monitoring Systems Market, Share by Supplier
Exhibit 3-20: Europe, Vital Signs
Monitoring Systems, Combined Market Forecast, 2006-2011
4. NEUROLOGIC PATIENT MONITORING PRODUCTS
MARKET
4.1
Clinical Overview
4.1.1 Traumatic Brain Injury
4.1.2 Stroke
4.1.3 Cerebral Aneurysm
4.1.4 Brain Tumors
4.2
Intracranial Pressure Monitoring
4.2.1 Products and Technologies
4.2.2 Market Analysis
4.2.3 Competitive Analysis
4.3
Cerebral Blood Gas Monitoring
4.3.1 Products and Technology
4.3.2 Market Analysis
4.3.3 Competitive Analysis
4.4 Neurologic Monitoring Systems,
Combined Market Analysis
Exhibit 4-1:
Europe, Incidence of Aggregate Hospitalized plus Fatal Traumatic
Brain Injuries
Exhibit 4-2: Europe, Deaths from
Stroke for Men
Exhibit 4-3: Europe, Deaths from
Stroke for Women
Exhibit 4-4: Europe, Incidence
of Tumors of the Brain and Central Nervous System
Exhibit 4-5: 2008, Selected Intracranial
Pressure Monitoring Systems
Exhibit 4-6: Europe, Intracranial
Pressure Monitors, Market Forecast, by Country, 2006-2011
Exhibit 4-7: Europe, Single-Use
Intracranial Pressure Catheters/Sensors, Market Forecast, by
Country, 2006-2011
Exhibit 4-8: Europe, Intracranial
Pressure Monitoring Products, Combined Market Forecast, 2006-2011
Exhibit 4-9: 2007, Europe, Intracranial
Pressure Monitoring Products Market, Share by Supplier
Exhibit 4-10: 2008, Selected Cerebral
Blood Gas Monitoring Products
Exhibit 4-11: Europe, Cerebral
Blood Gas Monitors, Market Forecast, by Country, 2006-2011
Exhibit 4-12: Europe, Cerebral
Blood Gas Sensors, Market Forecast, by Country, 2006-2011
Exhibit 4-13: Europe, Cerebral
Blood Gas Monitoring Products, Combined Market Forecast, 2006-2011
Exhibit 4-14: 2007, Europe, Cerebral
Blood Gas Monitoring Products Market, Share by Supplier
Exhibit 4-15: Europe, Neurologic
Monitoring Systems, Combined Market Forecast, 2006-2011
5. LEVEL OF CONSCIOUSNESS PATIENT
MONITORING PRODUCTS MARKET
5.1
Products and Technologies
5.1.1 Aspect Medical Systems
5.1.2 Danmeter
5.1.3 GE Healthcare/General Electric
5.1.4 Hospira
5.1.5 MT MonitorTechnik
5.1.6 Developments and Trends
5.2
Market Analysis
5.3
Competitive Analysis
Exhibit 5-1: Selected Areas of
Application for Level of Consciousness Monitoring Products
Exhibit 5-2: 2008, Selected Level
of Consciousness Monitoring Systems
Exhibit 5-3: Europe, Level of
Consciousness Monitoring Systems, Combined Market Forecast,
2006-2011
Exhibit 5-4: Europe, Level of
Consciousness Monitoring Systems, Combined Market Forecast,
by Country, 2006-2011
Exhibit 5-5: Europe, Level of
Consciousness Monitors, Market Forecast, by Country, 2006-2011
Exhibit 5-6: Europe, Level of
Consciousness Sensors, Market Forecast, by Country, 2006-2011
Exhibit 5-7: 2007, Europe, Level
of Consciousness Monitoring Systems Market, Share by Supplier
6. HEMODYNAMIC MONITORING PRODUCTS
MARKET
6.1 Pulmonary Artery Catheterization
versus Noninvasive and Minimally Invasive Cardiac Output Monitoring
6.2 Pulmonary Artery Catheters
6.2.1 Indications for Use
6.2.2 The Debate Over Pulmonary Artery
Catheterization
6.2.3 Products and Technologies
6.2.3.1 Arrow International/Teleflex
Medical/ Teleflex
6.2.3.2 Becton Dickinson
6.2.3.3 Edwards Lifesciences
6.2.3.4 Hospira
6.2.4 Market Analysis
6.2.5 Competitive Analysis
6.3 Noninvasive and Minimally Invasive
Hemodynamic Monitoring
6.3.1 Technologies
6.3.1.1 Bioimpedance
6.3.1.2 Esophageal Doppler Ultrasound
6.3.1.3 Fick Partial Rebreathing
6.3.1.4 Arterial Waveform Analysis
6.3.2 Products
6.3.2.1 Arrow International/Teleflex
Medical/Teleflex
6.3.2.2 CardioDynamics International
6.3.2.3 Deltex Medical
6.3.2.4 LiDCO
6.3.2.5 PULSION Medical Systems
6.3.2.6 Respironics/Philips Healthcare/Royal
Philips Electronics
6.3.3 Market Analysis
6.3.4 Competitive Analysis
6.4 Hemodynamic Monitoring Systems,
Combined Market Forecast
Exhibit 6-1: 2008, Selected Pulmonary
Artery Catheters
Exhibit 6-2: Europe, Pulmonary
Artery Catheters, Market Forecast, 2006-2011
Exhibit 6-3: France, Pulmonary
Artery Catheters, Market Forecast, 2006-2011
Exhibit 6-4: Germany, Pulmonary
Artery Catheters, Market Forecast, 2006-2011
Exhibit 6-5: Italy, Pulmonary
Artery Catheters, Market Forecast, 2006-2011
Exhibit 6-6: Spain, Pulmonary
Artery Catheters, Market Forecast, 2006-2011
Exhibit 6-7: United Kingdom,
Pulmonary Artery Catheters, Market Forecast, 2006-2011
Exhibit 6-8: 2007, Europe, Pulmonary
Artery Catheters Market, Share by Supplier
Exhibit 6-9: How Impedance Cardiography
Works
Exhibit 6-10: 2008, Selected Noninvasive
and Minimally Invasive Hemodynamic Monitoring Systems
Exhibit 6-11: Europe, Noninvasive
and Minimally Invasive Hemodynamic Monitoring Products, Market
Forecast, by Country, 2006-2011
Exhibit 6-12: Europe, 2007, Noninvasive
and Minimally Invasive Hemodynamic Monitoring Systems Market,
Share by Supplier
Exhibit 6-13: Europe, Hemodynamic
Monitoring Systems, Combined Market Forecast, 2006-2011
7.
COMPANY PROFILES
7.1
Aspect Medical Systems, Inc.
7.2
CardioDynamics International Corporation
7.3
Danmeter AS
7.4
Deltex Medical Group PLC
7.5
Edwards Lifesciences Corporation
7.6
General Electric Company
7.7
Hospira, Inc.
7.8
Integra LifeSciences Holdings Corporation
7.9
Johnson & Johnson
7.10
Mindray Medical International LTD/Shenzhen Mindray Bio-Medical
Electronics Company LTD
7.11
Opto Circuits India LTD
7.12
OSI Systems, Inc.
7.13
PULSION Medical Systems AG
7.14
Royal Philips Electronics NV
7.15
Somanetics Corporation
7.16
Teleflex, Inc.
7.17
Welch Allyn, Inc.
APPENDIX:
COMPANY LISTING